Switzerland Updates Decentralized Trials Paper To Align With EU, US Standards

Companies looking to conduct decentralized clinical trials in Europe can now easily see how Switzerland’s rules and processes compare with those of EU member states.

Sponsors now have more clarity on how to perform decentralized trials in Switzerland. (Shutterstock)
Key Takeaways
  • Swissmedic has updated its guidance on decentralized clinical trials (DCTs), and made it easier for companies to compare Swiss requirements with those of EU member states.

Switzerland’s medicines regulator, Swissmedic, has overhauled its position paper on decentralized clinical trials (DCTs) to align with guidance issued by...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Clinical Trials

More from R&D